Since 2021, Amazon's research and development (R&D) spending in the ICT sector was valued at over 43 billion U.S. dollars. It was followed by Google, with R&D spending worth 34 billion U.S. dollars in 2022.

In 2026, Swiss-based Roche is projected to spend 14 billion U.S. dollars on pharmaceutical research and development. Other companies with high projected R&D expenditures are Merck, Pfizer, and Johnson & Johnson. Expenditure per country The United States is projected to spend between 605 and 635 billion U.S. dollars on medicine in 2025. Current expenditures, as well as future estimates for the United States, are significantly higher than those of other high-spending countries, such as Japan and Germany. Japan, for example, is expected to spend between 75 and 95 billion U.S. dollars on pharmaceuticals that year. Johnson & Johnson Johnson & Johnson is a major pharmaceutical company, which had a total employee count of about 135 thousand people in 2020, headquartered in New Jersey, United States. The multinational company produces various pharmaceutical products, including Telara, Remicade, Zytiga, Imbruvica, and Darzalex. In 2020, Stelara was Johnson & Johnson’s top drug, earning the company almost 7.7 billion U.S. dollars in revenue. However, Johnson & Johnson has also significant medical devices and consumer products divisions.

This statistic shows the expenditure on research and development of biotech company Amgen from 2020 to 2024, by category. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. Amgen's R&D expenditure amounted to approximately six billion U.S. dollars in 2024. Of that amount, some 2.8 billion U.S. dollars were spent on later stage clinical programs.

Industrial research and development (R&D) spending in the ICT sector registered a steady increase over the period under consideration. In 2022, R&D spending amounted to *** billion U.S. dollars, registering an increase of nearly **** percent since 2021.

This statistic displays a forecast of the annual value of research and development (R&D) expenditures in the chemical industry in the United States from 2016 to 2020. In 2019, the total R&D expenditure in the chemical industry is expected to reach ***** billion U.S. dollars. Appreciation of the U.S. dollar is likely to reduce costs and increase production in the chemical industry. The capacity of the chemical industry is also continuing to increase and will likely contribute to innovation and more efficient production.

Amazon spent the most on research and development in the fiscal year 2024, with over ** billion U.S. dollars. Alphabet, Meta, Apple, and Microsoft rounded out the top five of companies with the highest R&D spending that year. Leading by innovation Spending money on research and development, or R&D, is how a company innovates new technologies and conducts research to develop new products and services. R&D allows companies, such as Amazon, to stay ahead of their competition and work towards the future. Most of the R&D spending in the world in 2022 was within health & pharma, which should be seen in light of the COVID-19 pandemic, and the United States is the leading country for R&D expenditure in the world. AI and R&D Currently, many companies are investing in Artificial Intelligence (AI) innovation, including the ethical implications of AI and how it can be used to better society as a whole. Major companies, such as Amazon and Alphabet, are throwing their collective weight into this issue and conducting research into its future applications.

Global research and development (R&D) spending in the advanced materials and chemical industry was forecast at roughly **** billion U.S. dollars in 2022. R&D spending in this sector worldwide has remained relatively stable in recent years.

In 2023, the highest share of research and development spending (R&D) was made within the software and internet developing industry, accounting for a total of nearly 19.1 percent of the global R&D spending. The health sector and hardware producers followed in second and third at around 18 and 26 percent respectively. In total, global R&D spending reached 2.5 trillion U.S. dollars in 2022. Health industry and COVID-19 The high share spent by the health industry must be seen in relation with the COVID-19 pandemic that started spreading in late 2019 and caused deaths, lockdowns, and restrictions throughout 2020 and onwards. As governments and pharmaceutical companies sought to find an efficient vaccine against the virus, investment in research continued to increase. However, regardless of the pandemic, R&D spending within health care is essential in order to combat a variety of diseases, from small pox via malaria to cancer. Information and communication technology As people around the world become more and more dependent on information and communication technology, research spending by companies producing hardware and software continues to increase as these seek to further develop. For instance, all the seven companies with the highest R&D spending in 2022 were either software or hardware producing companies. The largest single investor was the software giant Amazon.

Toyota incurred research and development (R&D) costs of about *** trillion Japanese yen in the fiscal year ended March 31, 2025. Not only is the Toyota Motor Corporation Japan’s largest automotive manufacturer, it is also ranked as the number one carmaker worldwide in terms of automobile production. Toyota’s research and development expenses The weak yen clearly helped Toyota export more vehicles. However, the company was hit hard by the 2008/2009 worldwide financial crisis, and its research and development expenses hit rock bottom in the fiscal year of 2010, only to finally reach pre-crisis levels in the fiscal year of 2014. In 2022, Toyota was among the leading automotive companies with the highest spending on research and development. Toyota's R&D costs crossed the *** trillion yen mark in 2019 and continued to notch up in 2020. The fiscal year of 2021 showed a slight decrease year-on-year. However, R&D expenses bounced back to *** trillion Japanese yen a year after.

In 2020, semiconductor research and development (R&D) spending in the United States accounted for 18.6 percent of industry sales, whilst spending in Europe occupied 17.1 percent of sales.

In 2024, research and development spending in the pharmaceutical industry stood at *** billion U.S. dollars globally. For comparison, R&D expenditures totaled *** billion dollars in 2016. Pharmaceutical R&D includes all steps from the initial research of disease processes, the compound testing over pre-clinical, and all clinical trial stages. At a certain point in the process – mostly during the pre-clinical phase – a governmental authority is involved to overview, regulate, and ultimately approve the drug. In the United States, the Food and Drug Administration is the principal agency associated with processes. The pressure to innovate In comparison to other industries, pharmaceutical companies are more driven by the imperative to manufacture innovative products, and thus to spend significant amounts on research and development. This is largely due to the time-limited patent protection of drugs and the following threat of sales erosion through generic and biosimilar competition. Two major effects of patent expirations for the pharma industry are a specific high R&D intensity and a growing focus on specialty drugs to diversify their product portfolio. The latest trends For the last several years, major developments in pharmaceutical research and development have begun to change the R&D landscape. A growing number of drug manufacturers are outsourcing large parts of R&D, mostly to clinical research organizations (also contract research organizations), with the main aim to reduce costs. Another important development is the use of big data in clinical research. Thus, a predictive modeling is possible which uses clinical and molecular data to develop safer and more efficient drugs. Particularly, real-time or real-world evidence (RWE) is becoming a greater interest. This makes cooperation with technology companies necessary and includes data gathered from various sources, even that of social media.

In 2024, total R&D expenses of biotech company BioNTech SE stood at some 2.25 billion U.S. dollars, of which over two billion euros were spent on non-COVID-19 products. On November 9th, 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.

Research and development (R&D) spending was forecast to reach over 2.47 trillion U.S. dollars globally in 2022 (once local currencies are converted for purchasing power parity). This compares to around one trillion U.S. dollars in 2005, and around 555 billion U.S. dollars in 1996. Spending decreased somewhat in 2020 following the outbreak of COVID-19, but increased again in 2021 and was forecast to do so in 2022 too.

This statistic highlights the trend in research and development (R&D) expenditure of the LVMH Group worldwide from 2008 to 2020. In 2019, LVMH Group's global R&D expenditure amounted to about 139 million euros.

In 2024, LG Energy Solution spent more than ************ South Korean won on its research and development (R&D) activities. This was a slight increase from the previous year. The main products of the company were small batteries for smartphones and laptops, automotive batteries supplied to major carmakers, and Energy Storage Systems (ESS).

This statistic shows research and development expenditure of AeroGrow International worldwide from 2015 to 2020. In 2020, the company spent *** thousand U.S. dollars on research and development.

In 2021, Indonesia invested around **** percent of its GDP in research and development (R&D). This was forecast to remain the same in 2022. Compared to other countries in Southeast Asia, Singapore had the highest investment in its research and development, at *** percent of its GDP.

In 2021, Vietnam's research and development (R&D) expenditure amounted to approximately *** billion U.S. dollars. The country's expenditure on R&D equaled around *** percent of its GDP that year. This was forecast to increase slightly in 2022.

This statistic shows the expenditure on research and development by UK businesses operating in the food product, beverages and tobacco product industries from 2003 to 2020. In 2020, expenditure on R&D reached *** million British pounds.

This statistic displays the distribution of current research and development expenditures of the pharmaceutical industry in Canada from 2020 to 2023, by region. In 2023, Quebec contributed 32.5 percent of the country's pharmaceutical R&D spending.